China Universal Asset Management Co., Ltd. Ironwood Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $1.17 Billion
- Q3 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 28,472 shares of IRWD stock, worth $89,402. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,472
Previous 32,501
12.4%
Holding current value
$89,402
Previous $23,000
60.87%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding IRWD
# of Institutions
189Shares Held
160MCall Options Held
11.2MPut Options Held
11.7K-
Black Rock Inc. New York, NY22.9MShares$71.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$50.7 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$50.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$50 Million13.13% of portfolio
-
Bank Of America Corp Charlotte, NC11.7MShares$36.7 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $481M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...